| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1995;25:124-131.)
© 1995 American Heart Association, Inc.
Articles |
Hypertrophy and Hyperplasia of Smooth Muscle Cells of Small Intramyocardial Arteries in Spontaneously Hypertensive Rats
From the Department of Pathology, University of Heidelberg (K.A., H.G.), and the Department of Pathology, Städtische Kliniken Darmstadt (S.S., G.M.) (Germany).
Correspondence to Prof Dr Gerhard Mall, Pathologisches Institut der Städtischen, Kliniken Darmstadt Grafenstr 9, D-64283 Darmstadt, FRG.
Abstract Hearts of stroke-prone spontaneously hypertensive rats (SHR) were investigated by means of stereology and were compared with those of normotensive Wistar-Kyoto controls. At the age of 9 months, hypertensive rats showed cardiac hypertrophy, marked myocardial fibrosis, activation of nonvascular interstitium, focal myocytial degeneration, reduction of capillarization, and microarteriopathy of small intramyocardial arteries. Stereologically, a significant increase in the total left ventricular arterial wall volume (+180% versus controls) was found in SHR hearts. By using new stereological techniques, the orientator and the nucleator, we investigated whether this significant increase in total left ventricular arterial wall volume was due to hyperplasia of smooth muscle cells in addition to the process of vascular smooth muscle cell hypertrophy that is common in SHR. Additionally, the nuclear size and ratio of cell volume to nuclear volume were determined using another new stereological technique, the selector. The stereological data indicate a significant increase in mean cell and nuclear volumes as well as in the total number of left ventricular arterial smooth muscle cells of SHR. Additionally, the total length of intramyocardial arteries was also significantly increased in hypertensive rats. The volume and number of arterial smooth muscle cells per arterial length were significantly (P<.001 and P<.05, respectively) higher in SHR than in normotensive controls. Thus, we conclude that hypertrophy and hyperplasia of smooth muscle cells are involved in intramyocardial arterial growth processes in hypertensive heart remodeling. Hyperplasia may be responsible for the realization of physiological growth processes, eg, length increase in the intramyocardial arterial tree, whereas hypertrophy predominantly causes the remarkable increase in the total wall volume of left ventricular intramyocardial arteries in stroke-prone SHR.
Key Words: hypertrophy • hyperplasia • muscle, smooth • arteries • rats, inbred SHR
This article has been cited by other articles:
 |
|
 |
|
  C. Ootaki, M. Yamashita, Y. Ootaki, K. Kamohara, S. Weber, R. S. Klatte, W. A. Smith, A. L. Massiello, S. N. Emancipator, L. A.R. Golding, et al. Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 150 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Feihl, L. Liaudet, B. I. Levy, and B. Waeber Hypertension and microvascular remodelling Cardiovasc Res, May 1, 2008; 78(2): 274 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sakaguchi, K. Tambara, Y. Sakakibara, M. Ozeki, M. Yamamoto, G. Premaratne, X. Lin, K. Hasegawa, Y. Tabata, K. Nishimura, et al. Control-Released Hepatocyte Growth Factor Prevents the Progression of Heart Failure in Stroke-Prone Spontaneously Hypertensive Rats Ann. Thorac. Surg., May 1, 2005; 79(5): 1627 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Schiffrin and R. M. Touyz From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446. [Full Text] [PDF]
|
|
|
|
|
|
S.'i. Kihara, K. N. Litwak, L. Nichols, P. Litwak, M. V. Kameneva, Z. Wu, R. L. Kormos, and B. P. Griffith Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist Ann. Thorac. Surg., January 1, 2003; 75(1): 178 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Dries, D. V. Exner, B. J. Gersh, H. A. Cooper, P. E. Carson, and M. J. Domanski Racial Differences in the Outcome of Left Ventricular Dysfunction N. Engl. J. Med., February 25, 1999; 340(8): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. TÖRNIG, M.-L. GROSS, A. SIMONAVICIENE, G. MALL, E. RITZ, and K. AMANN Hypertrophy of Intramyocardial Arteriolar Smooth Muscle Cells in Experimental Renal Failure J. Am. Soc. Nephrol., January 1, 1999; 10(1): 77 - 83. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. R. Weir, S. G. Chrysant, D. A. McCarron, M. Canossa-Terris, J. D. Cohen, P. A. Gunter, A. J. Lewin, R. F. Mennella, L. W. Kirkegaard, J. H. Hamilton, et al. Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives Hypertension, May 1, 1998; 31(5): 1088 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakano, A. Moriguchi, R. Morishita, I. Kida, N. Tomita, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara Role of Angiotensin II in the Regulation of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Experimental Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1448 - 1454. [Abstract] [Full Text]
|
|
|
|
|
|
K. Amann, B. Wolf, C. Nichols, J. Tornig, U. Schwarz, M. Zeier, G. Mall, and E. Ritz Aortic Changes in Experimental Renal Failure: Hyperplasia or Hypertrophy of Smooth Muscle Cells? Hypertension, March 1, 1997; 29(3): 770 - 775. [Abstract] [Full Text]
|
|